Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma Journal Article


Authors: Wolden, S. L.; Wexler, L. H.; Kraus, D. H.; LaQuaglia, M. P.; Lis, E.; Meyers, P. A.
Article Title: Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma
Abstract: Purpose: To determine the preliminary results of intensity-modulated radiotherapy (IMRT) for head-and-neck rhabdomyosarcoma. Methods and Materials: Twenty-eight patients underwent IMRT as a part of multimodality therapy. Twenty-one tumors were parameningeal, three were orbital, and four were in other sites. The median age was 8 years (range, 1-29 years). Most (89%) had Group III disease. Intracranial extension was present in 71% of parameningeal tumors. A 1.5-cm margin was used, and the median dose was 50.4 Gy (range, 30-55.8 Gy). Results: The actuarial 3-year survival rate for patients with parameningeal tumors was 65%. The 3-year actuarial freedom from failure rate was 95% locally, 90% in regional nodes, 88% in the central nervous system, and 80% at distant sites. No failures occurred among patients with orbit tumors; a single central nervous system failure occurred in 1 patient with a lip/cheek tumor. Disease-free survival was significantly worse for patients with alveolar histologic features (p = 0.01). Acute radiation toxicity was similar to that reported by the Intergroup Rhabdomyosarcoma Study Group. Late radiation toxicity was recorded and was mild. Conclusion: IMRT with image fusion results in outstanding local control despite the use of a reduced margin. However, survival among patients with alveolar histologic findings or intracranial extension remains unacceptably low. © 2005 Elsevier Inc.
Keywords: adolescent; adult; cancer survival; child; clinical article; child, preschool; disease-free survival; cancer patient; cancer radiotherapy; tumor localization; metastasis; radiotherapy dosage; radiotherapy; patient monitoring; histology; groups by age; central nervous system; statistical significance; infant; head and neck cancer; intensity-modulated radiotherapy; tumors; head and neck neoplasms; dosimetry; imaging; radiotherapy, conformal; cancer control; rhabdomyosarcoma; toxicity; head and neck; diseases; orbit tumor; neurology; dosimeters; multimodality therapy; intensity-modulated radiotherapy (imrt); lip tumor; intracranial extension; recording
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 61
Issue: 5
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2005-04-01
Start Page: 1432
End Page: 1438
Language: English
DOI: 10.1016/j.ijrobp.2004.08.005
PUBMED: 15817347
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 33" - "Export Date: 24 October 2012" - "CODEN: IOBPD" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dennis Kraus
    268 Kraus
  2. Eric Lis
    138 Lis
  3. Suzanne L Wolden
    560 Wolden
  4. Leonard H Wexler
    191 Wexler
  5. Paul Meyers
    311 Meyers
Related MSK Work